CI
IBB icon

Chartist Inc’s iShares Biotechnology ETF IBB Stock Holding History

Chartist Inc’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-259,854
Closed -$12.2M – 33
2017
Q1 		$12.2M Sell
259,854
-2,292
-0.9% -$219K 5.97% 5
2016
Q4 		$11.1M Sell
262,146
-3,174
-1% -$289K 5.64% 5
2016
Q3 		$11.3M Buy
265,320
+250,272
+1,663% +$23.8M 5.94% 5
2016
Q2 		$1.29M Buy
+15,048
New +$1.35M 0.69% 6
2015
Q4 		$1.75M Buy
+15,492
New +$1.68M 0.87% 6
2015
Q3 		– Sell
-101,628
Closed -$12.6M – 24
2015
Q2 		$12.6M Sell
101,628
-2,037
-2% -$244K 6.06% 3
2015
Q1 		$12.2M Sell
103,665
-900
-0.9% -$99.3K 5.77% 3
2014
Q4 		$10.7M Sell
104,565
-3,039
-3% -$295K 5.01% 3
2014
Q3 		$9.57M Sell
107,604
-372
-0.3% -$32.6K 5.01% 3
2014
Q2 		$9.17M Sell
107,976
-909
-0.8% -$71.6K 4.48% 4
2014
Q1 		$8.22M Sell
108,885
-1,002
-0.9% -$83.5K 4.39% 4
2013
Q4 		$8.31M Sell
109,887
-1,671
-1% -$119K 4.31% 4
2013
Q3 		$7.89M Sell
111,558
-3,213
-3% -$210K 4.53% 4
2013
Q2 		$6.9M Buy
+114,771
New +$6.63M 3.99% 7

Other funds holding IBB

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Chartist Inc's IBB Position: Q2 2017 in Review

Chartist Inc sold out of iShares Biotechnology ETF (IBB) in Q2 2017, closing a stake of 259,854 shares — an estimated $12.2M sold.

Chartist Inc first reported a position in IBB in Q2 2013 and held it in 14 quarters. The position peaked at $12.6M in Q2 2015. 561 funds tracked by Wall St. Rank hold IBB as of Q2 2017.

  • Chartist Inc reported no remaining iShares Biotechnology ETF position as of Q2 2017 after selling out during the quarter.
  • Chartist Inc sold 259,854 iShares Biotechnology ETF shares in Q2 2017, an estimated $12.2M.
  • Chartist Inc first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 14 quarters.
  • Chartist Inc's iShares Biotechnology ETF position peaked at $12.6M in Q2 2015.
  • 561 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2017.

Based on Chartist Inc's 13F filing for Q2 2017, filed 15 Aug 2017.